GSA Capital Partners »

Engene Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Engene Therapeutics (ENGN) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $65k 37k 1.74

More positions owned by GSA Capital Partners

Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Spdr Series Trust St Shor Corp Etf (SPSB)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Agree Realty Corporation (ADC)
Bank Ozk (OZK)
PNM Resources (TXNM)
Essential Properties Realty reit (EPRT)
TJX Companies (TJX)
Everest Re Group (EG)
O'reilly Automotive (ORLY)
American Airls (AAL)
Medtronic SHS (MDT)
Northrop Grumman Corporation (NOC)

View all positions for GSA Capital Partners

Top funds holding Engene Therapeutics

BML Capital Management
Siren
Perceptive Advisors
Ameriprise Financial
Nextech Invest
ADAR1 Capital Management
Vestal Point Capital
Acorn Capital Advisors
Peapod Lane Capital
Balyasny Asset Management
Millennium Management
Renaissance Technologies
Citadel Advisors
Affinity Asset Advisors
UBS Group

View all funds holding Engene Therapeutics